Ramucirumab plus docetaxel after combination chemoimmunotherapy in patients with non-small cell lung cancer: A prospective observational study

被引：0
|
作者：
Yamada, T. [1 ]
Katayama, Y. [2 ]
Watanabe, S. [3 ]
Watanabe, K. [4 ]
Takeda, T. [5 ]
Chihara, Y. [6 ]
Shiotsu, S. [7 ]
Hibino, M. [8 ]
Harada, T. [9 ]
Takayama, K. [1 ]
机构：
[1] Kyoto Prefectural Univ Med, Pulm Med, Kyoto, Japan
[2] Kyoto Prefectural Univ Med, Resp, Kyoto, Japan
[3] Niigata Univ Med & Dent Hosp, Dept Resp Med & Infect Dis, Niigata, Japan
[4] Tokyo Metropolitan Canc & Infect Dis Ctr Komagome, Thorac Oncol & Resp Med Dept, Bunkyo Ku, Tokyo, Japan
[5] Japanese Red Cross Kyoto Daini Hosp, Resp Med, Kyoto, Japan
[6] Uji Tokushukai Med Ctr, Resp Med, Uji, Japan
[7] Kyoto First Red Cross Hosp Kyoto Daiichi Sekijyuj, Oncol, Kyoto, Japan
[8] Shonan Fujisawa Tokushukai Hosp, Resp Med, Fujisawa, Kanagawa, Japan
[9] Fukuchiyama City Hosp, Med Oncol, Fukuchiyama, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.608
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
529P
引用
收藏
页码：S1676 / S1676
页数：1
相关论文
共 50 条
  • [21] Simultaneous chylous ascites and chylothorax during ramucirumab plus docetaxel chemotherapy in a patient with non-small lung cell cancer
    Arai, Makoto
    Maruta, Susumu
    Fan, Meng Meng
    Imai, Chiaki
    Tawada, Akinobu
    Takiguchi, Yuichi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2019, 8 (03) : 114 - 117
  • [22] The Impact of EGFR Mutation Status and Brain Metastasis for Non-Small Cell Lung Cancer Treated with Ramucirumab plus Docetaxel
    Furuya, Naoki
    Ito, Kentaro
    Sakaguchi, Tadashi
    Hida, Naoya
    Kakinuma, Kazutaka
    Morikawa, Kei
    Inoue, Takeo
    Komase, Yuko
    Hataji, Osamu
    Mineshita, Masamichi
    ONCOLOGY, 2020, 98 (09) : 661 - 668
  • [23] Simultaneous chylous ascites and chylothorax during ramucirumab plus docetaxel chemotherapy in a patient with non-small lung cell cancer
    Makoto Arai
    Susumu Maruta
    Meng Meng Fan
    Chiaki Imai
    Akinobu Tawada
    Yuichi Takiguchi
    International Cancer Conference Journal, 2019, 8 : 114 - 117
  • [24] CYFRA 21-1 predicts efficacy of combined chemoimmunotherapy in patients with advanced non-small cell lung cancer: a prospective observational study
    Kataoka, Nobutaka
    Katayama, Yuki
    Yamada, Tadaaki
    Morimoto, Kenji
    Takeda, Takayuki
    Okada, Asuka
    Shiotsu, Shinsuke
    Chihara, Yusuke
    Yamada, Takahiro
    Hiranuma, Osamu
    Ota, Takahiro
    Harada, Taishi
    Hasegawa, Isao
    Nishioka, Naoya
    Iwasaku, Masahiro
    Tokuda, Shinsaku
    Takayama, Koichi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (08)
  • [25] Docetaxel (Taxotere) in combination with vinorelbine in non-small cell lung cancer
    Miller, V
    SEMINARS IN ONCOLOGY, 1999, 26 (03) : 12 - 14
  • [26] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Gutierrez-Sainz, Laura
    Cruz-Castellanos, Patricia
    Higuera, Oliver
    De Castro-Carpeno, Javier
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (10)
  • [27] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Laura Gutierrez-Sainz
    Patricia Cruz-Castellanos
    Oliver Higuera
    Javier de Castro-Carpeño
    Current Treatment Options in Oncology, 2021, 22
  • [28] Nail changes after treatment with docetaxel: A prospective analysis in patients with advanced non-small cell lung cancer
    Park, Se Hoon
    Nam, Eunmi
    Cho, Eun Kyung
    Shin, Dong Bok
    ANNALS OF ONCOLOGY, 2006, 17 : 307 - 307
  • [29] Nail toxicity after treatment with docetaxel: A prospective analysis in patients with advanced non-small cell lung cancer
    Hong, Junshik
    Park, Se Hoon
    Choi, Soo Jin
    Lee, Seok Ho
    Lee, Kyu Chan
    Lee, Jae-lk
    Kyung, Sun Young
    An, Chang Hyeok
    Lee, Sang Pyo
    Park, Jeong Woong
    Jeong, Sung Hwan
    Nam, Eunmi
    Bang, Soo-Mee
    Cho, Eun Kyung
    Shin, Dong Bok
    Lee, Jae Hoon
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (06) : 424 - 428
  • [30] Treatment rationale and design of the RAMNITA study A phase II study of the efficacy of docetaxel plus ramucirumab for non-small cell lung cancer with brain metastasis
    Tanimura, Keiko
    Uchino, Junji
    Tamiya, Nobuyo
    Kaneko, Yoshiko
    Yamada, Tadaaki
    Yoshimura, Kenichi
    Takayama, Koichi
    MEDICINE, 2018, 97 (23)
12345